









Purpose: Alternatives to hospital follow-up (HFU) following treatment for cancer have been 
advocated. Telephone follow-up (TFU) and patient-initiated follow-up are being 
implemented but it is unclear if these approaches will meet the preferences and needs of 
patients. This study aimed to explore the preferences of endometrial cancer patients and 
their levels of satisfaction with HFU and nurse-led TFU.      
Methods: A cross-sectional survey design was utilised and a questionnaire was administered 
to 236 patients who had participated in a randomised controlled trial comparing HFU with 
TFU for women diagnosed with Stage I endometrial cancer (ENDCAT trial).  
Results: 211 (89.4%) patients returned the questionnaire; 105 in the TFU group and 106 in 
the HFU group. The TFU group were more likely to indicate that appointments were on time 
(p < 0.001) and were more likely to report that their appointments were thorough 
(p=0.011). Participants tended to prefer what was familiar to them. Those in the HFU group 
tended to prefer hospital-based appointments while the TFU group tended to prefer 
appointments with a clinical nurse specialist, regardless of locality.  
 Conclusions: To provide patient centred follow-up services we need to ensure that patient 
preferences are taken into account and understand   that patients may come to prefer what 
they have experienced. Patient initiated approaches may become standard and preferred 
practice but TFU remains a high-quality alternative to HFU and may provide an effective 






Participants tended to prefer what they had experienced in terms of follow-up 
 
Overall, high levels of satisfaction with information and service were reported 
 
The telephone group were more likely to indicate that appointments were on time 
 
































In 2018 there were 43.8 million people worldwide living with a cancer diagnosis (Cancer 
Atlas, 2019). It is predicted that there will be four million cancer survivors in the United 
Kingdom (UK) by 2030 (Maddams et al., 2012). Mortality rates are falling globally, and not 
just in high income countries (Hashim et al., 2016). However, the incidence of endometrial 
cancer is rising, associated with the global problems of obesity and diabetes (Arnold et al., 
2015; Nagle et al., 2018). Since the early 1990s, endometrial cancer incidence rates have 
increased by 56% in women in the UK (Cancer Research UK, 2019a). Although incidence is 
rising, most (75%) endometrial cancers are diagnosed at an early stage. Five year survival for 
Stage 1 disease (confined to the uterus) is over 70% (Baekelandt and Castiglione, 2009). 
Similar survival rates are reported across Europe (Cancer Research UK, 2019b). The risk of 
recurrence is low (3% or less) for early stage disease and most recurrences are symptomatic 
(Fung-Kee-Fung et al., 2006, Jeppesen et al., 2017). Hence, increasing numbers of women 
treated for endometrial cancer will require information and support following treatment. 
 
Providing follow-up services following treatment for increasing numbers of cancer survivors 
puts added pressure on health care providers. The traditional medical model of follow-up 
comprises attendance at hospital-based clinic appointments at regular intervals over a 
number of years to monitor progress. This approach is unsustainable from a practical and 
economic perspective but replacing hospital follow-up (HFU) with models of care that are 
clinically effective, cost effective and meet patients’ needs is challenging.  
 
For gynaecological cancers, the intention of HFU is to detect recurrence of cancer at an early 




cancers rank detection of recurrence as the most important reason for attending follow-up 
(Kew et al., 2009). However, regular scheduled hospital consultations for patients treated 
for gynaecological cancers do not bring a survival benefit and early detection of recurrence 
does not improve outcomes (Baekelandt and Castiglione, 2009; Kew et al., 2005; Tjalma et 
al., 2004). Despite the lack of evidence to support a clinical benefit, HFU remains common 
practice for gynaecological cancers (Leeson et al., 2013).  
 
Providing follow-up services for patients treated for endometrial cancer may be particularly 
problematic in terms of health care resources, given the number of survivors. A number of 
clinical trials are taking place across Europe that investigate different strategies for follow-
up of endometrial cancer patients (Leeson et al., 2017). So far, findings from two trials have 
been reported.   
 
The ENDCAT trial, carried out in the UK, compared HFU with nurse-led telephone follow-up 
(TFU) for 259 women diagnosed with Stage 1 endometrial cancer (Beaver et al., 2017). In 
the TFU arm, clinical nurse specialists administered a structured telephone intervention 
intended to provide patients with the information they needed. High levels of satisfaction 
were evident for both study arms with no physical or psychological detriment reported from 
foregoing face-to-face consultations and clinical examinations. An economic evaluation 
indicated that the TFU service was no more costly to the National Health Service (NHS) than 
hospital-based follow-up (Dixon et al., 2018). Telephone appointments were convenient for 
patients, who appreciated the continuity of care provided by clinical nurse specialists 





The OPAL study, carried out in Denmark, compared patient initiated follow-up with HFU for 
156 women with Stage 1 endometrial cancer (Jeppesen et al., 2018). There were no 
scheduled hospital visits for patients randomised to patient-initiated follow-up, but patients 
were provided with information on signs and symptoms of recurrence and were given 
instructions on how to self-refer if they experienced any problems. While patient-initiated 
follow-up reduced health care use, fear of recurrence was slightly higher in the patient-
initiated follow-up arm. Fear of recurrence has been reported as the main reason for cancer 
patients wanting regular surveillance (Lewis et al., 2009).   
 
Although different approaches to cancer follow-up are being evaluated, it is not clear what 
patients prefer and preferences may not align with policy shifts away from hospital-based 
approaches. Gynaecological cancer patients may prefer specialist follow-up as hospital-
based specialists are perceived as having higher levels of competence and providing more 
reassurance (Fidjeland et al., 2018). A Norwegian study reported that detection of 
recurrence was rated by 93% of gynaecological cancer patients (n=239) as being very 
important, with follow-up for late effects being more important for younger age groups (<50 
years) and the clinical examination being more important for those who had experienced 
follow-up (Fidjeland et al., 2018). This implied that patients were not well informed as to the 
likely outcomes of hospital-based appointments and had an unrealistic view of what follow-
up was about (Fidjeland et al., 2018). A systematic review also reported that cancer patients 
were not aware of the limitations of HFU and were not aware of the lack of effectiveness of 





Patients may prefer more intensive hospital-based follow-up (Brandenbarg et al., 2017) but 
may not be offered this service due to resource constraints. If new strategies are being 
proposed (including TFU and patient-initiated follow-up) it is important to understand the 
preferences and needs of patients. However, asking individuals who have only experienced 
HFU what they prefer may not be a reliable indicator of preference. Patients may prefer 
what they know and what is familiar to them (Frew et al., 2010; Salkeld et al., 2000).  
 
Patient-initiated follow-up is being recommended for the more common types of cancer, 
especially for those at low risk of recurrence (NHS England, 2018) but it is unclear if this 
approach will meet the needs of patients. For example, Jeppesen et al. (2018) found that 
patients allocated to patient-initiated follow-up can experience an increased fear of 
recurrence. The Independent Cancer Taskforce in England proposed a strategy for providing 
holistic support from diagnosis onwards, including a consideration of patients’ physical, 
psychosocial, financial, information and support needs (Independent Cancer Taskforce, 
2015). The Taskforce reported that stratified follow-up pathways, including needs 
assessment, supported self-management, remote monitoring and re-entry pathways could 
be more effective approaches to follow-up than traditional medical models of follow-up.  
 
Promotion of patient centred care that meets the needs of patients is central to current 
thinking on health care service delivery (NHS England, 2019). There has been a decisive shift 
away from hospital-based models of follow-up, on completion of treatment for cancer, to 
alternative approaches such as TFU and patient-initiated approaches. However, it is unclear 
what patients prefer and whether their needs are met by alternative models of follow-up. 




who had experienced HFU and/or TFU after treatment for endometrial cancer and their 
levels of satisfaction with information and service. It was anticipated that familiarity with an 
alternative approach to HFU may result in different preferences to those reported for 
patients who had not experienced alternative approaches.  This study was carried out as 
part of the ENDCAT trial and was conducted on completion of the trial.   
 
2. Aim 
The aim of the study was to investigate preferences for type of follow-up, and satisfaction 
with information and service, for patients who had been treated for endometrial cancer and 




A survey design was used to address the aims of the study, focused on patients who had 
participated in the ENDCAT trial (Beaver et al., 2017). The ENDCAT trial was a randomised 
controlled trial that compared HFU with TFU. The current study is a cross sectional survey that was 
conducted on completion of the ENDCAT trial and included all those participants who had been 
randomised. Although this was a cross sectional survey, we took account of randomised group when 
carrying out the analysis to make comparisons between groups. 
 
3.2 Sample 
Women had been eligible to participate in the ENDCAT trial if they had been diagnosed and 
treated for Stage 1 endometrial cancer, were attending hospital clinics for routine 
monitoring, had no clinical signs of recurrence and no hearing impediment that would 




of the original 259 participants. Questionnaires were not sent to those who had indicated 
that they did not want to complete further questionnaires (n=10), had experienced a 
recurrence of disease (n=10), had been withdrawn from the study at their own request 
(n=2) or had died from unrelated causes (n=1). Socio-demographic data was collected at the 
time of recruitment. At the study end point, participants had been in the ENDCAT trial for a 
mean of 25 months (range 11 to 35 months).  Participants had been randomised to either 
HFU, delivered primarily by medical doctors but also by specialist nurses, or TFU delivered 
by specialist nurses. All participants had received HFU prior to recruitment but only those 
randomised to TFU received this service.  Questionnaires were sent to patients in November 
2014 and data collection continued through to March/April 2015 as reminders were sent to 
those who did not return the questionnaire. Participants were asked to reflect on their 
experiences across the ENDCAT study period. 
 
3.3 Access and Recruitment 
Participants in the ENDCAT trial had been recruited across five hospitals in the North West 
of England. Clinical staff had identified eligible patients in hospital outpatient clinics where 
women had been attending for routine surveillance post treatment.  Telephone follow-up 
had been introduced at the five hospitals specifically for the ENDCAT trial and had not been 
in operation prior to the study. Additional details on procedures followed in the trial have 





3.4 Patient Preference and Satisfaction Questionnaire 
The questionnaire was divided into five main sections. Questions were derived from 
previous questions used in a study on nurse-led telephone follow-up for women with breast 
(Beaver et al., 2009) and the ENDCAT trial (Beaver et al., 2017). Section 1 asked participants 
about their current follow-up status. That is, if they were still having follow-up 
appointments or not. An ‘other’ option was also included for participants to add further 
comment if their experience did not fit with the question.  
 
Section 2 asked participants to consider their levels of satisfaction with their appointments 
(hospital or telephone) and their overall satisfaction with information received. There were 
four questions in this section asking about levels of satisfaction with hospital appointments 
with a doctor, hospital appointments with a specialist nurse, telephone appointments with a 
specialist nurse, and overall levels of satisfaction. Each item was scored on a numeric rating 
scale ranging from 1 (very unsatisfied) to 10 (very satisfied). A ‘not applicable’ option was 
also available as those participants who had been randomised to HFU should not have 
received telephone appointments. Some participants in the TFU arm of the study did receive 
hospital based follow-up appointments (n=14 at 6 months post randomisation, n=17 at 12 
months post randomisation; Dixon et al., 2018) if the specialist nurse had any concerns that 
warranted a face to face consultation, usually to view a reported problem. Therefore, it was 
considered likely that some participants in the TFU arm would give a rating to HFU, based on 
their experiences prior to randomisation or as a result of being asked to attend a hospital 





Section 3 focused on seven specific aspects of the follow-up appointments; I felt able to ask 
questions at my follow-up appointment, I had my questions answered, my appointments 
were always on time, I felt anxious before my appointments, I felt reassured after my 
appointment, and my appointments were very thorough. Participants were asked to score 
each item on a four-point Likert type scale, including ‘always’, ‘most of the time’, 
‘sometimes’ and ‘never’. A ‘not applicable’ option was also available.  
 
Section 4 presented participants with a choice of eight different types of follow-up (Box 1). 
An ‘other’ option was also available and those who indicated ‘other’ were asked to explain 
what follow-up they would prefer. Participants were asked to indicate their top three 
choices by placing a 1, 2 or 3 next to the options that matched their favoured preferences. If 
participants had no preference, they could tick a ‘no preferences’ option and were not 
required to rate the preferences.  
 
Insert Box 1 here 
 
Section 5 was an open question asking participants if they had any comments to add 
concerning their follow-up care.  
 
3.5 Data Collection 
Ethical approval was obtained from the National Research Ethics Service in the UK (NRES 
reference number 11/NW/0648). Personal contact details for patients in the ENDCAT trial 
had been retained, with participant consent, for contact throughout the study (e.g. sending 




by post with a pre-paid return envelope. Written consent had been obtained from all study 
participants and completion and return of the questionnaire was taken as consent for 
continued participation.   
 
3.6 Analysis 
Descriptive statistics were used to describe the characteristics of the participants. Mean 
values and standard deviations (SD) were used to present the numeric rating scale data that 
measured the participant’s levels of satisfaction with their appointments and information 
received and independent-samples t-tests were used to compare group differences in 
means, using the Satterthwaite approximation for the degrees of freedom when the group 
variances appeared to differ. Higher scores indicated higher levels of satisfaction. 
Categorical data were reported in proportions (percentage) and differences between groups 
were tested using the Chi-Square test; Fisher’s exact test was used if any expected cell 
frequency was <5. P-values <0.05 were considered statistically significant.   
 
To obtain a rank order score for the follow-up preference data, first choice was awarded 
three points, second choice was awarded two points and third choice was awarded one 
point. For each preference option, the points were summed, and the total score used to 
rank participant’s preferences across the groups, with a higher score indicating a stronger 
preference. All the statistical analyses were performed using SPSS version 25 (SPSS Inc., 
Chicago, IL, USA). 
 
The qualitative data from the responses to the open-ended question were uploaded into 




were transferred verbatim and were read and re-read independently by two researchers 
(KB, SW). Comments were considered separately for the HFU and TFU groups and were 
initially coded according to whether they presented general comments in relation to follow-
up or more specific comments on aspects of follow-up. The general comments were then 
coded as to whether they presented a favourable or unfavourable view of follow-up while 
the specific comments were coded according to the precise element of follow-up that was 
mentioned.      
 
3. Results 
Questionnaires were sent to 236 eligible women and a total of 211 (89.4%) participants 
returned the questionnaire; 105 in the TFU group and 106 in the HFU group. Most of the 
participants in the TFU (n=77, 73.3%) and HFU (n=82, 77.4%) groups were still attending 
follow-up appointments. The participant characteristics at the time of original recruitment 
are shown in Table 1. The mean age was 64.8 years (ranging from 36 to 88 years). Those in 
the HFU group were, on average, younger than in the TFU group (63.5 vs 66.2 years). The 
majority self-defined as White British and over half of the participants had retired from 
work (n=125, 59.2%). All the participants had undergone surgery, and six received 
radiotherapy.  
 
Insert Table 1 here 
 
Both groups expressed high levels of satisfaction with the follow-up service they received, 
evidenced by mean scores ranging from 8.46 to 9.51 (Table 2). Although participants in the 




applicable’ or leaving the questions blank. It is not known why these 13 participants decided 
to rate TFU, as they were asked to comment on their follow-up consultations during the 
ENDCAT trial, but they may be have been referring to ad-hoc telephone contact with a 
specialist nurse that was initiated by participants. Hospital appointments with a specialist 
nurse and overall satisfaction with information received were ranked more highly by the 
TFU group (Table 2). Given the difference in age between groups, we investigated, using 
linear modelling, whether the effect of treatment arm on overall satisfaction was 
confounded by age. The difference in satisfaction between trial arms was not confounded 
by age (unadjusted difference = 0.61, p=0.023; adjusted difference = 0.58, p=0.032, with age 
effect p=0.45). 
 
Insert Table 2 here 
 
The TFU group were more likely to indicate that follow-up appointments were always on 
time compared to the HFU group (p < 0.001) (Table 3). In addition, the TFU group were 
more likely to report that their appointments were thorough compared to the HFU group 
(p=0.011). There were no statistically significant differences between groups in terms of 
being able to ask questions, having questions answered, feeling anxious prior to 
appointments and feeling reassured (Table 3). 
 
Insert Table 3 here 
 
Participants were asked to indicate their follow-up preferences across nine options. Table 4 




preferences for the HFU group were ‘I would prefer appointments at the hospital with a 
doctor’, ‘I would prefer my first hospital appointment with a doctor and then hospital 
appointments with a specialist nurse’ and ‘I would prefer appointments at the hospital with 
a specialist nurse’, with hospital appointments as a common denominator. The top three 
preference for the TFU group were ‘I would prefer my first hospital appointment with a 
doctor and then telephone appointments with a specialist nurse’, ‘I would prefer telephone 
appointments with a specialist nurse’ and ‘I would prefer appointments at the hospital with 
a specialist nurse’, with specialist nurses as a common denominator. There were 20 (9.5%) 
participants who expressed no preference. Two participants indicated ‘other’, although one 
of these participants made a comment about their follow-up rather than suggesting an 
alternative (“I feel it is important to have an examination”). One individual indicated that “I 
would prefer the first 5 appointments at the hospital, the rest on the telephone and the last 
at the hospital”.    
 
Insert Table 4 here 
 
The majority of participants (n= 148, 70.1%) provided a response to the open-ended 
question with comments evenly distributed across the HFU (n=75) and TFU (n=73) groups. 
Comments were overwhelmingly positive, regardless of group allocation.  Most comments 
were general in nature and related to high levels of satisfaction with health care staff and 
experiences of care and service.  
 
For the HFU group, more specific positive comments related to feeling reassured by hospital 




problem would be dealt with. Negative comments related primarily to needing more 
information on specific aspects of care, seeing different doctors at each appointment, long 
travelling distances and difficulties with car parking. Participants who needed more 
information identified the following information needs: symptoms of recurrence, 
information on support groups, and explanations for various symptoms being experienced.  
Being seen by different doctors at each hospital appointment was a cause for concern as 
participants perceived that each new doctor had little knowledge of their case.  
 
‘The quality of care from the doctors varied with each one. Some were ‘good’ others were 
not so good – one seems to have a poor knowledge of my case in spite of her assurance that 
she had read the notes!’ (ID66, HFU) 
 
 ‘Perhaps more information about possible reoccurrence of the cancer and symptoms to look 
for would have been helpful.’ (ID18, HFU) 
 
For the TFU group, more specific positive comments related to knowing who to contact if 
they had a problem, the convenience of TFU, and being reassured by the consultation. 
Negative comments related to a preference for face to face contact, missing the 
reassurance of a clinical examination, feeling isolated/unsettled and administrative 
problems with the organisation of telephone appointments.    
 
‘This study has showed me that I would prefer to be seen at the hospital although the phone 
calls are thorough. I would feel more settled seeing someone than talk over a telephone.’ 









This study focused on women who had been treated for Stage 1 endometrial cancer and 
aimed to investigate preferences for type of follow-up and satisfaction with information and 
service. Participants had experienced HFU and/or TFU by clinical nurse specialists. Both 
groups expressed high levels of satisfaction with service but the TFU group were more 
satisfied with the information received. This is perhaps not surprising as the nurse-led 
telephone intervention was intended to provide patients with the information they needed. 
Although there were differences in mean age between groups, the estimated difference in 
satisfaction between groups was not confounded by the age differences. Competence and 
knowledge, through access to information, are key components of patient empowerment 
and a sense of control over health care decision making (Jørgensen et al., 2018). Although 
some patients may prefer less information to others or prefer different sources of 
information, engaging in positive communication with health care professionals and having 
access to information are key facilitators to patient empowerment (Jørgensen et al., 2018). 
A key part of clinical nurse specialists’ role in cancer follow-up is to provide information and 
support to promote self-management and enable independence (Macmillan Cancer 
Support, 2014). Hence, interventions that are focused on information provision are likely to 





The TFU group were more likely to indicate that follow-up appointments were always on 
time compared to the HFU group. In the TFU arm, the clinical nurse specialists were 
handling their own case load of follow-up patients. In a hospital gynaecology oncology 
outpatient clinic there are both new and follow-up patients with differing diagnoses, stages 
of disease and treatment regimens. Keeping appointments to time is challenging in a busy 
hospital environment. We did not explore if patients were concerned about waiting times in 
hospital clinics but patients in an Australian study attributed waiting times to a ‘problem of 
the system’ and did not attribute blame to hospital staff; waiting times did not impact on 
trust in health care professionals (Ward et al., 2017). If patients are concerned about waiting 
times, the shift away from hospital-based approaches should be advantageous for patients.  
 
The TFU group were more likely to report that their appointments were thorough compared 
to the HFU group and this may relate to the nature of the telephone intervention, which 
was designed to elicit and discuss information needs. Hospital clinic appointments are brief, 
especially for follow-up patients, with little time to focus on both physical and psychological 
issues. However, over 90% of both groups indicated that their appointments were thorough 
‘always’ or ‘most of the time’. This is a positive finding but we did not explore in detail how 
‘thorough’ was defined by participants or their expectations of follow-up. A Canadian study 
reported that a large majority of endometrial cancer survivors were not aware of their risk 
for recurrence or how to monitor for this and were not provided with clear information in 
this regard (Jones et al., 2012). Participants in the Canadian study were also unclear about 
the late effects of cancer treatment, few had been told about the resources available to 
them and were not provided with information about self-management tools that could aid 





In the UK, a Recovery Package is advocated for all patients treated for cancer by the UK’s 
Department of Health, which includes holistic needs assessments, treatment summaries, 
patient education and wellbeing events and cancer care reviews in primary care 
(Department of Health, Macmillan Cancer Support & NHS Improvement, 2013). In theory, 
the Recovery Package should meet the information and support needs of patients and 
enable self-management. The Recovery Package is intended to be in place for all patients 
diagnosed with cancer by 2020, as indicated in the NHS England Five Year Forward View and 
the Cancer Taskforce Strategy (NHS England, 2014; Independent Cancer Taskforce, 
2015), but it is not clear if all the elements of the Recovery Package are in place as yet at a 
national level.    
 
Participants in this study tended to prefer the approach to follow-up that was familiar to 
them. This is encouraging for the implementation of alternative follow-up strategies as any 
new approach may not be favoured at the outset but, once patients have experienced it, 
views and preferences may alter. It would seem prudent to discuss the follow-up strategy to 
be implemented at an early stage in order that patient’s expectations of follow-up can be 
managed effectively and patients can be provided with the information and sources of 
support they will need throughout the recovery process to enhance the ability to self-
manage. The recent trend towards patient-initiated follow-up advocates a strong self-
management and empowerment component to follow-up care (Kirshbaum et al., 2017; 
Jeppesen et al., 2019). A recent UK study reported high levels of satisfaction when patient-
initiated follow-up was introduced for early stage endometrial cancer patients at a hospital 




made in the first six months of the scheme, primarily the reporting of physical symptoms, 
and younger women and women from ethnic minority groups were more likely to make 
contact, indicating that they needed greater levels of support (Kumarakulasingam et al., 
2019). If there is an initial discomfort in transferring from HFU to patient-initiated follow-up, 
then TFU may provide a stepping stone for those who require psychological support and 
reassurance for a while longer.  
 
Follow-up by a General Practitioner (GP) in primary care was not highly preferred by either 
group. Participants were more likely to prefer discharge from follow-up in preference to GP 
follow-up. This is an interesting finding as cancer care reviews in primary care are a key 
element of the Recovery Package advocated for all patients treated for cancer by the UK’s 
Department of Health (Department of Health, Macmillan Cancer Support & NHS 
Improvement, 2013). We did not explore if participants had experienced a cancer care 
review and it may be that participants did not prefer GP follow-up because they were not 
familiar with this type of follow-up. Patients who have received GP follow-up on completion 
of treatment for melanoma have reported higher levels of satisfaction, when compared to 
patients who received HFU, and have appreciated the convenience of GP follow-up as well 
as reporting more thorough consultations (Murchie et al., 2010a; Murchie et al., 2010b). A 
systematic review has advocated a greater role for GP’s in cancer follow-up care provision 
but also noted that patients may only feel comfortable accessing their GP for follow-up if 
they already have an established relationship (Meiklejohn et al., 2016).  Participants in our 
study may have felt able to self-manage their condition and not require regular structured 
appointments with a GP. More work is still required to determine how primary care 





Overall, participants expressed their satisfaction with both HFU and TFU, although 
responses to the open-ended question indicated that there were differing reasons between 
groups for the levels of satisfaction reported.  Participants in both groups were 
overwhelmingly positive about their experiences with staff and service. However, some 
participants in the HFU group lacked information and this may reflect the short duration of 
clinic appointments and lack of time available to discuss concerns. Some participants in the 
TFU group missed the reassurance of clinical examinations and felt more isolated, reflecting 
a lack of understanding on the likely outcome of the clinical examination. The responses to 
the open question cannot be considered akin to detailed and in-depth qualitative data but 
qualitative interview studies on TFU have indicated that patients treated for cancer 
appreciate the convenience of TFU and the continuity of care provider (Beaver et al., 2010, 
Cox & Faithfull, 2015; Williamson et al., 2015, Williamson et al., 2018).  
 
Increased provider continuity of care can lead to increased levels of patient satisfaction and 
better health outcomes (van Walraven et al., 2010). Maintaining continuity of care provider 
in a hospital clinic environment is challenging as junior doctors rotate on a regular basis, 
although clinical nurse specialists have more permanence. From an organisational 
perspective, continuity of care from a clinical nurse specialist is more realistic and feasible. 
This is reflected in our findings as patients who had experienced clinical nurse specialist led 
TFU tended to prefer contact with a nurse specialist. Clinical nurse specialists have been 
reported as key facilitators of supportive follow-up care (Davies and Batehup, 2011).  
Studies on TFU for patients treated for different types of cancer have utilised the skills of 




2012; Cox et al., 2008; Kimman et al., 2010; Shaida et al, 2007). However, clinical nurse 
specialists are a scarce resource (Macmillan Cancer Support, 2014) and it is unlikely that 
they could provide TFU for all cancer survivors. Although patient-initiated follow-up 
approaches do not involve scheduled appointments with health care professionals, the 
success of patient-initiated follow-up is dependent on patients being provided with the 
information they need to self-manage (David and Batehup, 2011) and specialist nurses will 
continue to have a key role as providers of information on alarm symptoms and self-referral 
processes. Hence, the involvement of clinical nurse specialist in the implementation of any 
new follow-up approach is key to meeting the needs of patients. 
 
No studies on alternative approaches to endometrial cancer follow-up have focused on 
survival as a primary outcome and it is not known if any of the approaches evaluated to date 
would prolong life. In the absence of such evidence it is important to focus on patient needs 
and preferences. A consideration of patients’ physical, psychosocial, financial, information 
and support needs has been advocated (Independent Cancer Taskforce, 2015). Stratified 
follow-up pathways that include holistic needs assessment, supported self-management, 
remote monitoring and re-entry pathways have been indicated as the way forward 
(Independent Cancer Taskforce, 2015), and early indications are that self-management 
approaches for those at low risk of recurrence can meet patients’ needs for information and 
support (Dickinson et al., 2014; Kirschbaum et al., 2017; Koinberg et al., 2004). Although we 
do not yet have a body of evidence on the clinical and cost effectiveness of self-
management approaches, this is unlikely to prevent implementation as resources are 
currently not available to provide hospital-based care to all cancer survivors. There is still a 




only experienced HFU may have a strong preference for continued hospital contact and may 
feel that patient-initiated follow-up is too drastic a step at a time when they feel vulnerable 
and continue to have concerns and information needs. TFU could provide a useful stop gap 
to meet patients’ needs but reduce the burden on hospital-based services. 
 
5. Limitations.  
Participants had taken part in a trial and therefore had agreed to undergo randomisation; 
they were all willing to experience either HFU or TFU. Hence, they did not have strong 
preferences to remain on HFU at the outset. This can be considered both a strength and a 
weakness;  a strength in that participants were open to trying a new approach and were not 
biased towards one approach or another but a weakness in that they may have been happy 
to report satisfaction with whatever approach they had been allocated. Patient satisfaction 
measures can be prone to ceiling effects, with patients tending to report high levels of 
satisfaction (Voutilainen et al., 2016). A further limitation is that we asked participants to 
report preferences for services they had received but also services they had not received 
(GP follow-up and patient-initiated follow-up). Participants may have been reluctant to state 
a preference for a service they had not experienced. The study sample were predominantly 
white British, which does not reflect the UK’s ethnic diversity or the inclusion/exclusion 
criteria for the ENDCAT trial as non-English speakers were not excluded from the study. It is 
not known why there was a lack of ethnic diversity within the sample but this may reflect 
the global challenge of ensuring representation of minority groups in cancer clinical trials 
(Chen et al., 2014, Symonds et al., 2012). Hence, more work is needed in this area to explore 







To provide truly patient-centred follow-up services for patients who have been treated for 
endometrial cancer we need to ensure that patient preferences are taken into account. 
However, this needs to be tempered with the knowledge that patients may come to prefer 
what they have experienced. Although the introduction of patient-initiated follow-up 
approaches may become standard and preferred practice for patients treated for different 
types of cancer, TFU remains a high-quality alternative to HFU and may provide an effective 
transition between HFU and patient-initiated follow-up.   
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• I would prefer appointments at the hospital with a doctor 
 
• I would prefer appointments at the hospital with a specialist nurse 
 
• I would prefer telephone appointments with a doctor 
 
• I would prefer telephone appointments with a specialist nurse 
 
• I would prefer my first hospital appointment with a doctor and then telephone 
appointments with a specialist nurse 
 
• I would prefer my first hospital appointment with a doctor and then hospital 
appointments with a specialist nurse 
 
• I would prefer to have my follow-up appointments with my General Practitioner (GP) 
 
• I would prefer to be discharged from follow-up after treatment as long as I know 
who to contact if I have a problem 
 
• Other (please explain)  
 





Table 1. Characteristics of the study sample (n=211) 
 
 Total (n=211) TFU (n=105) HFU (n=106) 
Age (years): Mean (SD)  64.8 (8.8) 66.2 (8.3) 63.5 (9.2) 
 n % n % n % 
Marital Status 







Divorced/separated 14 6.6 7 6.7 7 6.6 
Widowed 21 10.0 12 11.4 9 8.5 
Never married 13 6.2 8 7.6 5 4.7 
Employment Status 
Working full time 40 19.0 15 14.3 25 23.6 
Working part time 38 18.0 20 19.0 18 17.0 
Retired from work 125 59.2 65 61.9 60 56.6 
Unemployed  1 0.5 0 0.0 1 0.9 
Long term sick 3 1.4 2 1.9 1 0.9 
Never worked 4 1.9 3 2.9 1 0.9 
Educational level 
No formal qualifications 27 12.8 14 13.3 13 12.3 
Certificate/diploma/vocational 171 81.0 84 80.0 87 82.1 
Degree 13 6.2 7 6.7 6 5.7 
Ethnic group 
White 209 99.0 104 99.0 105 99.1 
Indian 1 0.5 1 1.0 0 0.0 
Polish 1 0.5 0 0.0 1 0.9 




Table 2. Satisfaction with service provider and information received 
 
 Group n mean SD T p 
Hospital appointments with a doctor HFU 99 8.78 2.23 -1.49 0.139 
TFU 57 9.21 1.40 
Hospital appointments with a 
specialist nurse 
HFU 63 8.83 2.12 -2.11 0.037 
TFU 49 9.51 1.29 
Telephone appointments with a 
specialist nurse 
HFU 13 8.46 2.79 -1.30 0.216 
TFU 102 9.48 1.17 
Overall, satisfaction with information 
received 
HFU 102 8.79 2.39 -2.29 0.023 
TFU 102 9.40 1.20 





Table 3. Satisfaction with service received 
 
  HFU TFU 2 df p 
  n % n %    
I felt able to ask questions at my follow-up appointments Always/Most of the time 99 95.2 102 98.1 1.33 1 0.445* 
Sometimes/Never 5 4.8 2 1.9    
I had my questions answered Always/Most of the time 99 96.1 103 99.0 1.87 1 0.212* 
Sometimes/Never 4 3.9 1 1.0    
My follow-up appointments were always on time Always/Most of the time 74 71.2 99 99.0 30.68 1 <0.001 
Sometimes/Never 30 28.8 1 1.0    
I felt anxious before my appointments Always/Most of the time 23 22.1 15 14.7 1.88 1 0.170 
Sometimes/Never 81 77.9 87 85.3    
I felt reassured after my appointments Always/Most of the time 96 91.4 95 95.0 1.03 1 0.311 
Sometimes/Never 9 8.6 5 5.0    
My appointments were very thorough Always/Most of the time 95 91.3 100 99.0 6.49 1 0.011 
Sometimes/Never 9 8.7 1 1.0    





Table 4. Preferences for follow-up 
 
Preference HFU TFU 
 Rank Score Rank Score 
I would prefer appointments at the hospital with a 
doctor 
1 171 5 50 
I would prefer my first hospital appointment with a 
doctor and then hospital appointments with a specialist 
nurse 
2 107 4 53 
I would prefer appointments at the hospital with a 
specialist nurse 
3 92 3 65 
I would prefer to be discharged from follow-up after 
treatment as long as I know who to contact if I have a 
problem 
4 50 6 41 
I would prefer my first hospital appointments with a 
doctor and then telephone appointments with a 
specialist nurse  
5 40 1 151 
I would prefer telephone appointments with a specialist 
nurse 
6 22 2 149 
I would prefer to have my follow-up appointments with 
my GP 
7 18 8 17 
I would prefer telephone appointments with a doctor 8 14 7 23 
 
HFU: hospital follow-up; TFU: Telephone follow-up 
 
 
